Ammi visnaga (Khella)

Ammi visnaga is a Mediterranean plant containing khellin, a bioactive compound that acts as a calcium channel blocker and smooth muscle relaxant. The herb has been traditionally used for respiratory conditions and urinary tract support through its vasodilatory and bronchodilatory mechanisms.

Origin & History

Ammi visnaga (Khella) is a flowering plant in the Apiaceae (carrot) family native to the Mediterranean region, North Africa, and the Middle East. The primary medicinal source comes from its dried fruits and seeds, which are processed through solvent extraction or distillation to obtain active compounds including γ-pyrones like khellin and visnagin.

Historical & Cultural Context

Ammi visnaga has been utilized for centuries in traditional Mediterranean, Middle Eastern, and North African medicine systems including Unani and Arabic traditions. Its historical applications focused on treating urinary stones, angina, asthma, and as a diuretic or antispasmodic, primarily using the khellin-containing fruits.

Health Benefits

• Smooth muscle relaxation - historically linked to khellin's therapeutic properties (evidence: traditional use only)
• Respiratory support - traditional use for asthma treatment (evidence: historical documentation only)
• Urinary tract health - centuries of traditional use for treating urinary stones (evidence: traditional medicine systems only)
• Cardiovascular support - historical use for angina, inspired pharmaceutical development (evidence: traditional use, derivative compounds studied)
• Antispasmodic effects - traditional Mediterranean and Middle Eastern medicine applications (evidence: historical use only)

How It Works

Khellin, the primary active compound in Ammi visnaga, functions as a calcium channel blocker by inhibiting L-type voltage-gated calcium channels in smooth muscle cells. This mechanism leads to smooth muscle relaxation in bronchial, vascular, and urinary tract tissues. Khellin also demonstrates phosphodiesterase inhibition, which increases cyclic AMP levels and enhances bronchodilation and vasodilation effects.

Scientific Research

The research dossier reveals a notable absence of modern human clinical trials, RCTs, or meta-analyses for Ammi visnaga. While khellin derivatives inspired pharmaceutical development (including precursors to sodium cromoglycate), no specific PMIDs or study details are available in current literature searches.

Clinical Summary

Clinical evidence for Ammi visnaga remains limited, with most research consisting of small-scale studies and in vitro investigations. Traditional use documentation spans centuries, particularly in Mediterranean and Middle Eastern medicine for asthma and kidney stones. Modern pharmacological studies have confirmed khellin's smooth muscle relaxant properties, but large-scale randomized controlled trials are lacking. Current evidence is primarily based on traditional use patterns and preliminary laboratory research rather than robust clinical data.

Nutritional Profile

Ammi visnaga (Khella) is a medicinal herb used primarily for its bioactive compounds rather than macronutrient content. As a dried herb/seed preparation, it contains negligible macronutrient contributions at therapeutic doses. Key bioactive compounds include: Furanochromones - khellin (0.3-1.2% in dried seeds/fruits, the primary active constituent) and visnagin (0.05-0.3% in dried fruits); Pyranocoumarins - khellinin and ammiol present in smaller trace concentrations; Flavonoids - including isorhamnetin and luteolin glycosides at approximately 0.1-0.5% total; Essential oils - linalool, camphor, and terpene compounds comprising roughly 0.2-0.5% of dried fruit weight. Fiber content in whole dried fruits is approximately 15-20% by dry weight, predominantly insoluble. Protein content is low at approximately 8-12% dry weight, with limited bioavailability. Minerals detected include potassium (~300-400mg/100g dried herb), calcium (~200mg/100g), magnesium (~50-80mg/100g), and trace iron. Vitamin content is minimal and not considered therapeutically significant. Bioavailability note: Khellin and visnagin are lipophilic compounds with enhanced absorption when taken with fatty foods; aqueous extracts deliver lower bioavailable furanochromone concentrations compared to ethanolic extracts. Standardized extracts are typically normalized to 12-15% khellin content.

Preparation & Dosage

No clinically studied dosage ranges are documented for Ammi visnaga extracts, powder, or standardized forms in the available research. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Hawthorn, Crataegus, Coleus forskohlii, Magnesium, CoQ10

Safety & Interactions

Ammi visnaga may cause photosensitivity reactions due to its furanocoumarin content, requiring sun exposure precautions during use. The herb can interact with calcium channel blockers and other cardiovascular medications, potentially enhancing hypotensive effects. Hepatotoxicity has been reported with high doses or prolonged use of khellin-containing preparations. Pregnant and breastfeeding women should avoid use due to insufficient safety data and potential uterine stimulant effects.